Objectives-The aim of this study was to detect left ventricular (LV) structure and function abnormalities in patients with type 2 diabetes mellitus with or without nonalcoholic fatty liver (NAFL) using 3-dimensional speckle-tracking echocardiography.
C ardiovascular disease is a common complication of type 2 diabetes mellitus, and it is also the main cause of death, disability, and reduced life quality in diabetic patients. 1, 2 Myocardial damage caused by type 2 diabetes usually has an insidious onset and a prolonged duration and is mainly characterized by left ventricular (LV) hypertrophy and systolic or diastolic dysfunction.
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Nonalcoholic fatty liver (NAFL) is widely prevalent in patients with type 2 diabetes, with an incidence exceeding 50%. 3, 4 Accumulating evidence suggests that NAFL is closely linked to risk factors for cardiovascular disease 5 ; however, the information regarding the impact of NAFL on cardiac function among patients with type 2 diabetes is limited. Using tissue Doppler imaging, Bonapace et al 6 found significantly impaired LV diastolic function only in patients with type 2 diabetes and NAFL compared to those without NAFL.
Three-dimensional (3D) speckle-tracking echocardiography is a highly reproducible technique for the assessment of LV volume and function. 7 More importantly, this technique is not angle dependent, does not require a high frame rate, and is not subject to out-ofplane speckle loss, all of which are inherent in other techniques used for quantitative myocardial analysis. 8, 9 Therefore, in this study, we investigated the application of this newly developed technique for the evaluation of preclinical LV abnormalities in patients with type 2 diabetes with or without NAFL and explored the effect of NAFL on the cardiac structure and function in this population.
Materials and Methods

Study Population
Patients in our outpatient and inpatient departments were enrolled from January to December 2016 according to the following inclusion criteria: (1) diagnosis of type 2 diabetes based on the 2014 guidelines of the American Diabetes Association 10 ; and (2) a left ventricular ejection fraction (LVEF) of 55% or higher. The following exclusion criteria were applied: (1) patients who had a history of hypertension or coronary artery stenosis diagnosed by coronary angiography and computed tomography; (2) patients with arrhythmia; (3) patients who had known causes of chronic liver disease (ie, alcoholic or drug-induced liver disease and autoimmune or viral hepatitis); and (4) patients with a poor acoustic window and fuzzy 3D images. In total, 80 patients were included in this study. The clinical diagnostic criteria for NAFL were defined as hepatic steatosis detected by abdominal ultrasonography (US) among individuals without a history of heavy drinking or other known causes of chronic liver disease.
We also recruited 40 age-and sex-matched healthy volunteers from our medical examination center as a control group. These individuals showed an absence of diabetes, hypertension, and coronary heart disease and no evidence of preexisting cardiac or hepatic disease in conventional radiologic, US, or laboratory tests. Written informed consent was obtained from every participant, and the retrospective study was approved by the local Ethics Committee (Luzhou, China).
Hepatic US
Hepatic US was performed with a commercially available abdominal diagnostic US apparatus and a 3.5-MHz transducer (Acuson S2000; Siemens AG, Erlangen, Germany). Fatty liver was diagnosed according to the following findings: (1) enhanced echogenicity of the liver relative to the kidneys; (2) decreased penetration of the US signal and lower visibility of the diaphragm; and (3) poor visualization of the borders of intrahepatic vessels. 11 The severity of fatty liver was divided into mild (slightly increased liver echogenicity, mildly attenuated penetration of the US signal, and slightly decreased clarity of the intrahepatic vessel borders and diaphragm), moderate (wide-ranging increase in liver echogenicity, marked attenuation of penetration of US signal, and decreased visualization of intrahepatic vessels walls and the diaphragm), and severe (gross increase in liver echogenicity, further reduction in penetration of the US signal, and poor or no visualization of intrahepatic vessels walls and the diaphragm; online supplemental Figure  1 ). 12 Scoring of the degree of hepatic steatosis for all scans was undertaken independently by 2 experienced experts in abdominal US. One of the following 4 grades of fatty liver was assigned: 0, none; 1, mild; 2, moderate; or 3, severe. The measure of concordance in the scoring between the experts was analyzed in terms of a j statistic.
Echocardiography
All conventional examinations were performed with a Vivid E9 US scanner (GE Healthcare, Waukesha, WI) and a cardiac M5S transducer. The chamber size, wall thickness and ejection fraction were measured according to the American Society of Echocardiography recommendations. 13 The transmitral inflow diastolic velocities (E and A) were obtained by spectral Doppler imaging, and the mitral annular diastolic velocities (E 0 and A 0 ) were obtained by tissue Doppler imaging.
14 These data were represented by the average values of 3 consecutive cycles.
Left ventricular mass was calculated by the following formula: LV mass (g) 5 0.8 3 [1.04(LV end-diastolic diameter 1 posterior wall end-diastolic diameter-1 interventricular septum end-diastolic diameter) 3 -(LV end-diastolic diameter) 3 1 0.6]. The LV mass index was then determined by dividing the LV mass by the body surface area. Left ventricular hypertrophy was defined as an LV mass index of 110 g/m 2 or higher in women and 125 g/m 2 or higher in men. 15 Relative wall thickness was the ratio of (interventricular septum enddiastolic diameter 1 posterior wall end-diastolic diameter)/LV end-diastolic diameter. A partition value of 0.42 or less for relative wall thickness was used for both healthy men and women. 13 Based on the LV mass index and relative wall thickness values, LV patterns were divided into 4 types: normal geometry (relative wall thickness 0.42 and absence of LV hypertrophy), concentric remodeling (relative wall thickness > 0.42 and absence of LV hypertrophy), concentric hypertrophy (relative wall thickness > 0.42 and presence of LV hypertrophy), and eccentric hypertrophy (relative wall thickness 0.42 and presence of LV hypertrophy). 16 We used a fully sampled matrix array transducer (GE 4V-D) for 3D data acquisition. An electrocardiographically gated LV full-volume data set was established on the basis of a standard apical 4-chamber view (Ap4C) from 6 consecutive cardiac cycles. Subsequently, another 5 live tomographic orientations of the apical 3-chamber, apical 2-chamber, mitral valve, papillary muscle, and apical short-axis sections were collected in the full-volume mode. The depth and angle were adjusted moderately so that the frame rate could be greater than 40% of the participant's heart rate.
GE 4D Automated Left Ventricular Quantification software was used to analyze the 3D images online. First, the points of mitral valve closing and the LV apex were determined manually in the apical 4-chamber view. The tracks of endocardial and epicardial borders in a single cycle were then detected automatically by the software. Necessary adjustments were made manually to achieve optimal LV delineation. Finally, the LV volume-time curve, LVEF, and regional and global strain values in multiple directions were provided by the system. The global longitudinal strain, global circumferential strain, global area strain, and global radial strain values were calculated by the software as the weighted averages of the segmental peak strain values (Figures 1-3 ).
Other Examinations
Blood pressure was measured at the right upper arm with a mercury sphygmomanometer after a 5-minute rest. Fasting venous blood samples were obtained for routine blood biochemical tests, including fasting plasma glucose, hemoglobin A 1c (HbA 1c ), serum lipids, alanine aminotransferase, and aspartate aminotransferase.
Intraobserver and Interobserver Reproducibility
Seven days later, 3D strain values were determined in 18 randomly selected participants by the same sonographer and independently by a second sonographer; both were blinded to the previous measurements. Intraobserver and interobserver reproducibility was described by the intraclass correlation coefficient.
Statistical Analyses
All statistical analyses were performed with SPSS version 17.0 software (IBM Corporation, Armonk, NY). Continuous variables were expressed as mean 6 standard deviation. One-way analysis of variance and post hoc least significant difference tests were used for multiple group comparisons. Categorical variables were shown as frequencies and compared by v 2 tests. A multivariate regression analysis was used to determine the independent predictors of global longitudinal strain, global circumferential strain, global area strain, and global radial strain in patients with type 2 diabetes. The presence or absence of NAFL (dichotomous variable) was treated as a dummy variable and assigned a value of 1 (presence of NAFL) or 0 (absence of NAFL). Two-sided P < .05 was considered to indicate statistical significance in all of the analyses.
Results
Diagnosis and Classification of NAFL
A total of 80 patients with type 2 diabetes were included in this study. Agreement between the experts in independent scoring of the scans was 96% (j 5 0.94; P < .001). There was disagreement between experts on the scoring of only 3 scans. Two scans were scored as moderate fatty liver by expert 1 but severe fatty liver by expert 2, and 1 scan was scored as severe fatty liver by expert 1 but moderate fatty liver by expert 2. These 3 scans were rescored by a third expert and then classified according to a common consensus. Finally, the diagnoses by US included 40 patients (50%) without fatty liver, 13 with mild fatty liver (16%), 14 with moderate fatty liver (18%), and 13 with severe fatty liver (16%).
Baseline Clinical Data
Patients with type 2 diabetes and NAFL had significantly higher serum alanine aminotransferase levels than patients with type 2 diabetes without NAFL and the control group (P < .01; P < .001). Patients with diabetes and NAFL also had significantly higher fasting plasma glucose levels, HbA 1c levels, systolic blood pressure, diastolic blood pressure, total cholesterol levels, and lowdensity lipoprotein cholesterol levels than the control group (P < .001; P < .05; P < .01). However, only the fasting plasma glucose, HbA 1c , total cholesterol, and low-density lipoprotein cholesterol levels were significantly higher in patients with diabetes than the control group (P < .001; P < .01), whereas there were no statistically significant differences in the remaining variables among the groups (Table 1) .
Conventional Echocardiographic Data
With regard to the cardiac structure, the left atrial volume, LV wall thickness, and LV mass index values were significantly higher in the patients with diabetes and NAFL than in both the controls (P < .001; P < .01; P < .05) and the patients with diabetes only (P < .001; P < .05). However, only the relative wall thickness was significantly higher in patients with diabetes only than the controls (P < .05). There were no significant differences among the groups in terms of the LV diameters.
With regard to the cardiac function, the patients with diabetes and NAFL had significantly higher E 0 /A 0 and E/E 0 ratios than both the controls (P < .001; and P < .01) and the patients with diabetes only (P < .05). The patients with diabetes only also had a significantly higher E 0 /A 0 ratio than the controls (P < .05). No significant differences in the 2-dimensional (2D) ejection fraction and E/A ratio were found among the groups (Table 2) . Two-Dimensional LV Geometric Pattern Significant differences were found in the constituent ratios of the 4 types of LV patterns among the groups. Compared to the normal LV geometry, which accounted for a larger proportion of the controls (85%), the abnormal LV patterns appeared more frequently in the patients with type 2 diabetes without and with NAFL (22.5% and 42.5%, respectively). Moreover, LV hypertrophy (including concentric and eccentric hypertrophy) was most prevalent in the patients with diabetes and NAFL (17.5%; Table 3 and Figure 4 ). 
Three-Dimensional Morphologic Data
There were no significant differences in the end-diastolic volume, end-systolic volume, and ejection fraction among the 3 groups (P > .05). Conversely, the 3D LV mass was significantly higher in the patients with diabetes and NAFL than both the controls and the patients with diabetes only (P < .05; Table 4 ).
Three-Dimensional Strain Parameters
The global longitudinal strain, global circumferential strain, and global radial strain values were significantly lower in patients with type 2 diabetes only than the controls (P < .001; P < .05; P < .01). Furthermore, the patients with diabetes and NAFL had severely lower global longitudinal strain, global circumferential strain, global area strain, and global radial strain values than the control group (all P < .001), and they also had similar global circumferential strain values (P > .05) but severely lower global longitudinal strain, global area strain, and global radial strain values than the patients with diabetes only (all P < .001; Table 4 and Figure 5 ).
Predictive Factors for 3D Strain in Patients With Type 2 Diabetes
In the multivariate regression, the absolute values were used to replace the negative 3D strain parameters, and the main baseline clinical data were prespecified as independent variables based on their statistical significance and the prior published information. The HbA 1c level was independently associated with global longitudinal strain (b 5 2.678; P < .001), global circumferential strain (b 5 2.667; P < .001), global area strain (b 5 2.673; P < .001), and global radial strain (b 5 2.661; P < .001). Nonalcoholic fatty liver was also independently associated with global longitudinal strain (b 5 2.343; P < .001), global area strain (b 5 2.307; P < .001), and global radial strain (b 5 2.225; P 5 .010) but not with global circumferential strain (b 5 2.104; P 5 .225). In addition, the BMI was only related to global longitudinal strain (b 5 2.188; P 5 .009; Table 5 ).
Left Ventricular Systolic Function in Patients With
Type 2 Diabetes and Varying Severity of NAFL There were no significant differences in general clinical and conventional echocardiographic data among the subgroups with varying severity of NAFL, with the exception of the larger left atrium and higher E/E 0 ratio found in patients with type 2 diabetes and moderate and severe steatosis (online supplemental Tables 1 and 2 ). In the 3D speckle-tracking echocardiographic analysis, the patients with moderate steatosis had significantly lower global longitudinal strain, global area strain, and global radial strain values than those with mild steatosis (all P < .05). Furthermore, the patients with severe steatosis had significantly lower global longitudinal strain, global circumferential strain, global area strain, and global radial strain values than those with mild steatosis (P < .001; P < .05). There were no significant differences in the strain values between the patients with diabetes and moderate and severe hepatic steatosis (all P > .05; Table 6 ).
Reproducibility of 3D Strain Values
The intraclass correlation coefficient values of intraobserver and interobserver variability for 3D LV strain are shown in Table 7 . 
Discussion
In this study, we compared the LV structure and function in patients with type 2 diabetes with or without NAFL using 3D speckle-tracking echocardiography. The major findings were as follows: (1) Significant differences in LV patterns were found among the 3 groups. (2) The patients with diabetes only had significantly lower global longitudinal strain, global circumferential strain, and global radial strain than the controls. (3) The patients with diabetes and NAFL had severely lower global longitudinal strain, global circumferential strain, global area strain, and global radial strain than the controls, and they also had severely lower global longitudinal strain, global area strain, and global radial strain than the patients with diabetes only. (4) The HbA 1c level and NAFL were independently associated with LV strain values in all patients with diabetes. (5) The strain values in multiple directions decreased significantly in the patients with diabetes and moderate and severe NAFL than in those with mild NAFL.
Abnormality of 2D LV Geometry
Type 2 diabetes has traditionally been considered a risk factor for myocardial thickening. 17 However, the incidence and extent of myocardial hypertrophy in type 2 diabetes were relatively lower than those in hypertension. 18 In this study, we only observed a slight uptrend (not significant enough) in inter-ventricular septum and LV posterior wall thickness from the controls to the patients with diabetes without NAFL. Correspondingly, the abnormal LV patterns (concentric remodeling and concentric hypertrophy) also increased mildly in patients with diabetes without NAFL compared to the controls. On the contrary, the patients with diabetes and NAFL had a significantly higher wall thickness and LV mass index than the controls and the patients with diabetes without NAFL. Therefore, the abnormal LV patterns, especially concentric hypertrophy and eccentric hypertrophy, were significantly more prevalent in this group than in the other groups.
The close relationship between NAFL and LV hypertrophy had been reported previously in certain populations. In a large-scale cross-sectional study of a general Korean population, Jung et al 19 found that individuals with NAFL had a significantly higher LV mass index (height, 2.7) compared to those without NAFL. Sert et al 20 observed significantly higher LV mass measurements in obese adolescents with NAFL than in those without NAFL. In a study similar to ours, Mantovani et al 21 also revealed that US-diagnosed NAFL was a positive independent predictor of LV hypertrophy in hypertensive patients with type 2 diabetes.
Although the underlying mechanisms of NAFLassociated LV hypertrophy remain speculative, the systemic release of some potential mediators from the steatotic and inflamed liver has generally been considered the most possible reason. Endothelin 1 and a wide array of proinflammatory and oxidative stress biomarkers were all included. 22 More recently, the alanine aminotransferase level was also found to be positively correlated with interventricular septum thickness and LV mass in patients with NAFL. 23 It could be inferred from our study that an elevated alanine aminotransferase level could be another important factor in the higher proportion of LV hypertrophy in the patients with type 2 diabetes and NAFL. The patients with diabetes and NAFL had the synergistic effect of 2 risk factors, which made them have more abnormalities in the LV geometry.
Left Ventricular Systolic Dysfunction on 3D SpeckleTracking Echocardiography Myocardial strain can reflect the degree of myocardial deformation under tension, and it is the basic descriptor BMI indicates body mass index; GAS, global area strain; GCS, global circumferential strain; GLS, global longitudinal strain; GRS, global radial strain; HR, heart rate; and SBP, systolic blood pressure. of the myocardial nature and function. Furthermore, because of the capacity for precise quantitative measurements at the millimeter level, strain has become an important index for evaluation of systolic function. Three-dimensional speckle-tracking echocardiography is an emerging technique, which is being applied for detection of myocardial strain. This technique can track genuine 3D motion without angle dependence or out-ofplane speckle loss and provide strain information closer to the truth. In our study, conventional 2D echocardiography showed a slight increase in LV remodeling combined with significantly lower diastolic function in the patients with type 2 diabetes only compared to the controls, whereas 3D speckle-tracking echocardiography further showed the subclinical systolic dysfunction in multiple directions in these patients. Usually, LV diastolic dysfunction has rarely been seen in isolation, and it was always associated with a certain degree of subclinical systolic dysfunction. 24 However, this systolic dysfunction was insidious and was easily masked by a normal LVEF, with the true situation reflected only by reduced strain values.
Multiple pathophysiologic changes induced by type 2 diabetes have been found to contribute to myocardial damage, such as energy metabolism disorder, microvascular lesions, and autonomic nervous dysfunction. 25 Due to the strong compensation mechanism, these unfavorable factors might not cause a significantly decreased LVEF in the early stage but could increase the myocardial stiffness, resulting in reduced systolic strain values. Additionally, the reduction in global longitudinal strain was more significant than that in global circumferential strain and global radial strain. The most likely explanation was that the longitudinal fibers located in the endocardium were more sensitive to harmful factors such as ischemia, hypoxia, and pressure loading. 26 In addition to the significantly impaired E 0 /A 0 and E/E 0 ratios measured by 2D echocardiography, 3D speckle-tracking echocardiography in this study further showed greater LV systolic dysfunction in the patients with type 2 diabetes and NAFL. They had severely lower global longitudinal strain, global circumferential strain, global area strain, and global radial strain than the controls and also had severely lower global longitudinal strain, global area strain, and global radial strain than the patients with diabetes only (all P < .001). On the basis of previous reports, we found that NAFL induced varying degrees of LV systolic dysfunction. The main possible mechanism widely accepted by the public is elevated insulin resistance in fatty liver. 27, 28 Fotbolcu et al 29 observed that the systolic velocity detected by tissue Doppler imaging was significantly decreased in patients with NAFL compared to that in a control group. Karabay et al 30 also reported that the LV global longitudinal strain and strain rate measured by 2D speckle-tracking echocardiography were significantly lower in patients with NAFL than in controls. Moreover, in a study similar to ours, Singh et al 31 found that obese patients with NAFL had significantly lower LV global longitudinal strain than those without NAFL. In our study, NAFL and type 2 diabetes were both risk factors for increased insulin resistance; therefore, the combination of the two could lead to more serious LV dysfunction.
Additionally, NAFL has been considered the hepatic manifestation of a metabolic disturbance and even a novel component of metabolic syndrome. 32, 33 Previously published studies have demonstrated the superimposed negative effect of multiple metabolic disorders on LV systolic function. Wong et al 34 reported that LV longitudinal systolic velocity, strain, and strain rate measured by tissue Doppler imaging were gradually reduced with increasing metabolic scores in patients with metabolic syndrome. Tadic et al 35 also found similar results using 2D speckle-tracking echocardiography. In this study, our findings revealed that the combination of type 2 diabetes and NAFL could lead to more severe LV systolic dysfunction than that associated with type 2 diabetes alone.
Independent Factors Associated With LV Strain
The multiple regression analysis indicated that HbA 1c and NAFL were correlated with LV systolic strain in patients with type 2 diabetes. The relationship between the glucose level and LV function has been demonstrated in numerous studies. Iribarren et al. 36 demonstrated an increased (1.56-fold) risk of heart failure in patients with type 2 diabetes and poorly controlled blood glucose compared to those with well-controlled blood glucose. Shi et al 37 identified an association between elevated serum HbA 1c levels and a decreased LVEF. Our previous study also confirmed that fasting plasma glucose was a significant negative influential factor affecting global longitudinal strain in patients with type 2 diabetes. 38 The potential mechanisms included excessive deposition of advanced glycation end products, 39 increased oxidative stress, 40 and hyperactivation of protein kinase C. 41 A few studies demonstrated a correlation between NAFL and pathophysiologic cardiac changes. Emre et al 42 found that a fatty liver disease score of 3 or higher was an independent predictor of the absent myocardial blush grade in patients undergoing a primary percutaneous coronary intervention. Pacifico et al 43 reported that NAFL was significantly associated with increased E/e 0 ratio and Tei index in obese children. In our study, we identified a negative relationship between NAFL and global longitudinal strain, global area strain, and global radial strain. From the perspective of a quantitative analysis of myocardial motion, these findings revealed the adverse impact of NAFL on cardiac systolic function in patients with type 2 diabetes. In addition, we found that the correlation between NAFL and global circumferential strain was not significant enough (b 5 2.094; P 5 .297), which could partly explain why there was no significant difference in global circumferential strain values between patients with type 2 diabetes with and without NAFL.
Effects of Varying Severity of NAFL on LV Function
With the exception of the larger left atrium and higher E/E 0 ratio, which indicated lower diastolic function in patients with type 2 diabetes who had moderate and severe NAFL, there were no significant differences in the remaining conventional echocardiographic measurements, including the 2D and 3D LVEF, among the subgroups. However, the significant decrease in strain values suggested that the patients with type 2 diabetes who had moderate and severe NAFL had lower LV subclinical systolic function than those with mild NAFL. Some studies have shown a higher prevalence of coronary artery calcification and multivessel coronary artery disease in patients with moderate-to-severe NAFL compared to those with mild NAFL. 44, 45 In this study, our results indicated that among the patients with type 2 diabetes, even in the absence of apparent coronary artery lesions, moderate and severe NAFL could cause greater cardiac diastolic and systolic dysfunction than mild NAFL.
Limitations
This retrospective study had some limitations. First, the number of patients in this cross-sectional study was relatively small, which was especially obvious in the comparison of subgroups with varying severity of NAFL.
However, even with such a small number of patients, our results showed the difference in 3D LV strain among these subgroups. Second, there were several restrictions in terms of the 3D speckle-tracking technology itself. For example, 6 sequential beats of volume acquisition were required to establish the full-volume database; therefore, potential instabilities in the cardiac position and beat-to-beat variations were unavoidable during the multibeat process. In addition, the low spatial resolution of 3D images contributed to low image definition. Finally, compared to pathologic biopsy, which is the reference standard for the diagnosis of NAFL, US-based techniques are associated with lower sensitivity and specificity. However, the former procedure is highly invasive and not acceptable to many patients, whereas the noninvasive US method can be performed repeatedly.
Conclusions
In patients with type 2 diabetes, the high prevalence of coexistent NAFL could aggravate LV hypertrophy and dysfunction even though the LVEF was preserved. The combined application of conventional echocardiography and 3D speckle-tracking echocardiography could detect these structural and functional abnormalities at a subclinical level.
